Brain
aging is commonly associated with neurodegenerative disorders,
but the ameliorative effect of krill oil and the underlying mechanism
remain unclear. In this study, the components of krill oil were measured,
and the antiaging effects of krill oil were investigated in mice with d-galactose (d-gal)-induced brain aging via proteomics
and gut microbiota analysis. Krill oil treatment decreased the expression
of truncated dopamine- and cAMP-regulated phosphoproteins and proteins
involved in the calcium signaling pathway. In addition, the concentrations
of dopamine were increased in the serum (p < 0.05)
and brain (p > 0.05) due to the enhanced expressions
of tyrosine-3-monooxygenase and aromatic l-amino acid decarboxylase.
Moreover, krill oil alleviated gut microbiota dysbiosis, decreased
the abundance of bacteria that consume the precursor tyrosine, and
increased the abundance of Lactobacillus spp. and
short-chain fatty acid producers. This study revealed the beneficial
effect of krill oil against d-gal-induced brain aging and
clarified the underlying mechanism through proteomics and gut microbiota
analysis.